98%
921
2 minutes
20
The 5 alpha-reductase deficiency is one of the significant causes of the disorders of sex development (DSD) in individuals bearing 46 XY chromosomes. The conversion of testosterone into dihydrotestosterone is impaired on account of this enzyme deficiency. The mutations in the steroid 5 alpha-reductase type 2 gene (SRD5A2) result in the deficiency of this enzyme. We hereby report three cases of DSD presented in the Pediatric Department of Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab. The current study was carried out to identify the subtype of DSD in children born to non-consanguineous parents of two families recruited from South West Punjab. Proband 1, belonging to Family 1, was 4.5 years old, whereas Probands 2 and 3 from Family 2 were siblings of 4 years and 2 years of age. All the patients presented with clitoral enlargement and other features, including palpable swellings in the labia majora and bilateral labioscrotal folds. The DNA of the affected children was subjected to exome sequencing. All three were found to be homozygous for c.737G > A: p.R246Q alteration. This was confirmed by Sanger Sequencing and, at the same time, parents were found to be heterozygous. The clinical examination, radiological investigation, hormonal profiling, and the mutation confirmed that all the probands were affected with pseudo vaginal perineoscrotal hypospadias, a subtype of DSD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10508-025-03197-0 | DOI Listing |
Arch Esp Urol
August 2025
Department of Urology, The Characteristic Medical Center of PLA Rocket Force, 100088 Beijing, China.
Background: We conducted a meta-analysis to compare the efficacy and drug-related adverse events (AEs) of the combination of tamsulosin and dutasteride versus tamsulosin monotherapy for the treatment of benign prostatic hyperplasia (BPH).
Methods: Relevant articles published in PubMed, Embase and Cochrane from 2004 to 2024 were searched and downloaded. These studies were screened following pre-established inclusion criteria, and data were extracted.
Can J Urol
August 2025
Department of Medicine, University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, 110095, India.
Objectives: Benign prostatic hyperplasia (BPH) is a common benign tumor in men, with an age-related prevalence of multifactorial etiology. The present study aimed to accurately assess and predict the effect of co-existing metabolic syndrome (MtS) upon treatment outcomes of combination medical therapy in select patients of lower urinary tract symptoms (LUTS) due to BPH.
Methods: After obtaining informed consent from the patients, 70 eligible patients with LUTS due to BPH with and without MtS were enrolled in this study from September 2022 to January 2024 from the outpatient clinic at the University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi and were treated with a combination of Tamsulosin and Dutasteride, for two months, as per the protocol.
J Cosmet Dermatol
September 2025
Medical Department, Cantabria Labs Difa Cooper, Milano, Italy.
Background: Minoxidil and finasteride are currently the only FDA-approved pharmacological treatments for androgenic alopecia (AGA) and female androgenic alopecia (FAGA). However, substantial improvement is observed in no more than 20% of patients in the medium term. To enhance clinical responses, nonpharmacological dietary supplementation is often utilized.
View Article and Find Full Text PDFAm J Mens Health
August 2025
Faculty of Medical Sciences, Goce Delcev University, Stip, North Macedonia.
Age-related decline in dehydroepiandrosterone (DHEA) and its sulfate metabolite, dehydroepiandrosterone-sulfate (DHEAS), affects steroid synthesis in men. DHEA(S) acts as a direct neurosteroid and weak androgen and is the unique steroid unaffected by dutasteride's inhibitory effect on 5α reductases. This study examined the relationship between dutasteride's side effects, specifically erectile dysfunction (ED) and mood disorders, and the age-related decline in DHEAS.
View Article and Find Full Text PDFArch Sex Behav
August 2025
Department of Human Genetics and Molecular Medicines, Central University of Punjab, Bathinda, 151401, India.
The 5 alpha-reductase deficiency is one of the significant causes of the disorders of sex development (DSD) in individuals bearing 46 XY chromosomes. The conversion of testosterone into dihydrotestosterone is impaired on account of this enzyme deficiency. The mutations in the steroid 5 alpha-reductase type 2 gene (SRD5A2) result in the deficiency of this enzyme.
View Article and Find Full Text PDF